Literature DB >> 1332704

Structure-activity studies of the thrombin receptor activating peptide.

T Sabo1, D Gurwitz, L Motola, P Brodt, R Barak, E Elhanaty.   

Abstract

Cleavage of the human platelet thrombin receptor by thrombin exposes a new N-terminal which acts as a putative tethered ligand. A synthetic peptide--"SFLL" (SFLLRNPNDKYEPF), corresponding to the new N-terminal region, activates and induces platelet aggregation and serotonin secretion. We have found that the pentapeptide--SFLLR is the minimal peptide length which retains full activity in inducing [14C]serotonin secretion. Structure-activity relationship studies were performed on this pentameric peptide. Systematic replacement of all amino acids with L-Ala indicated the importance of F-2, L-3 and R-5 for activity. Further studies demonstrated that the positive charge at the N-terminus, but not at the C-terminus of the pentapeptide, is crucial for activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1332704     DOI: 10.1016/0006-291x(92)91099-c

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor.

Authors:  P Andrade-Gordon; B E Maryanoff; C K Derian; H C Zhang; M F Addo; A L Darrow; A J Eckardt; W J Hoekstra; D F McComsey; D Oksenberg; E E Reynolds; R J Santulli; R M Scarborough; C E Smith; K B White
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

2.  Contractile actions of thrombin receptor-derived polypeptides in human umbilical and placental vasculature: evidence for distinct receptor systems.

Authors:  J Tay-Uyboco; M C Poon; S Ahmad; M D Hollenberg
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

Review 3.  Cellular consequences of thrombin-receptor activation.

Authors:  R J Grand; A S Turnell; P W Grabham
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

4.  Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue.

Authors:  M Saifeddine; B al-Ani; C H Cheng; L Wang; M D Hollenberg
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

5.  Regulation of neurite outgrowth from differentiated human neuroepithelial cells: a comparison of the activities of prothrombin and thrombin.

Authors:  A S Turnell; D P Brant; G R Brown; M Finney; P H Gallimore; C J Kirk; T R Pagliuca; C J Campbell; R H Michell; R J Grand
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

6.  Vascular actions of thrombin receptor-derived polypeptides: structure-activity profiles for contractile and relaxant effects in rat aorta.

Authors:  A A Laniyonu; M D Hollenberg
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

7.  Relaxant and contractile responses of porcine pulmonary arteries to a thrombin receptor activating peptide (TRAP).

Authors:  E Glusa; M Paintz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-04       Impact factor: 3.000

8.  Plasmin modulates the thrombin-evoked calcium response in C6 glioma cells.

Authors:  J S Turner; G T Redpath; J E Humphries; S L Gonias; S R Vandenberg
Journal:  Biochem J       Date:  1994-01-01       Impact factor: 3.857

9.  Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators.

Authors:  L F Lau; K Pumiglia; Y P Côté; M B Feinstein
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

10.  Glycoprotein Ib activation by thrombin stimulates the energy metabolism in human platelets.

Authors:  Norma Corona de la Peña; Manuel Gutiérrez-Aguilar; Ileana Hernández-Reséndiz; Álvaro Marín-Hernández; Sara Rodríguez-Enríquez
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.